NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
-39.7%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $22.50M | -50.6% |
| 2024 | $45.56M | +223.4% |
| 2023 | $14.09M | -86.3% |
| 2022 | $102.69M | - |
| 2021 | $0.00 | - |
| 2020 | $0.00 | - |